Pages that link to "Q37177882"
Jump to navigation
Jump to search
The following pages link to Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis (Q37177882):
Displaying 50 items.
- C/EBPα Dysregulation in AML and ALL (Q22065117) (← links)
- Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group (Q27853039) (← links)
- CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population (Q31111079) (← links)
- Myeloid neoplasias: what molecular analyses are telling us (Q33354547) (← links)
- Long-term follow-up of cytogenetically normal CEBPA-mutated AML (Q34233639) (← links)
- Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD. (Q34502042) (← links)
- The multifaceted functions of C/EBPα in normal and malignant haematopoiesis. (Q34502869) (← links)
- Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association (Q34635511) (← links)
- The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression (Q34649120) (← links)
- Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype. (Q35788613) (← links)
- Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia (Q36457184) (← links)
- Detection of CEBPA double mutants in acute myeloid leukemia using a custom gene expression array (Q36789391) (← links)
- Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification (Q36849666) (← links)
- Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia (Q36925156) (← links)
- The potential of a single enhancer (Q37015672) (← links)
- Recognizing familial myeloid leukemia in adults (Q37073883) (← links)
- Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family (Q37216459) (← links)
- Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations (Q37331218) (← links)
- Nanochannel Electroporation as a Platform for Living Cell Interrogation in Acute Myeloid Leukemia. (Q37422939) (← links)
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (Q37624593) (← links)
- Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives (Q37712353) (← links)
- Molecular mechanisms underlying deregulation of C/EBPalpha in acute myeloid leukemia (Q37737625) (← links)
- Acute Myeloid Leukemia Diagnosis in the 21st Century (Q37798016) (← links)
- Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectives (Q37815040) (← links)
- Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia (Q37957404) (← links)
- The use of molecular genetics to refine prognosis in acute myeloid leukemia (Q38198569) (← links)
- Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms (Q38344558) (← links)
- Mutations in AML: prognostic and therapeutic implications (Q39027793) (← links)
- Biological and clinical consequences of NPM1 mutations in AML. (Q39098284) (← links)
- The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice. (Q39363419) (← links)
- Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia (Q39451939) (← links)
- The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China (Q40202671) (← links)
- Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia (Q41197435) (← links)
- BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia (Q41885481) (← links)
- Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis. (Q42113668) (← links)
- Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'. (Q42543838) (← links)
- Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset (Q43111395) (← links)
- CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia. (Q43466307) (← links)
- Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia (Q43579359) (← links)
- The role of different genetic subtypes of CEBPA mutated AML. (Q43746366) (← links)
- NPM1, FLT3-ITD, CEBPA, and c-kit mutations in 312 Chinese patients with de novo acute myeloid leukemia (Q44959828) (← links)
- Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients (Q45176487) (← links)
- Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model (Q45876973) (← links)
- Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis (Q46086559) (← links)
- Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment (Q47660404) (← links)
- Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor (Q48242145) (← links)
- The added values of multiplex reverse transcriptase-PCR followed by mutation screening in the initial evaluation of acute leukemia. (Q51694552) (← links)
- Who should be transplanted in first remission of acute myeloid leukaemia? (Q53402031) (← links)
- Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia. (Q54307737) (← links)
- Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features (Q54405300) (← links)